HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Abstract
B cells are pivotal regulators of acquired immune responses, and recent work in both experimental murine models and humans has demonstrated that subtle changes in the regulation of B cell function can substantially alter immunological responses. The balance of negative and positive signals in maintaining an appropriate B cell activation threshold is critical in B lymphocyte immune tolerance and autoreactivity. FcγRIIb (CD32B), the only recognized Fcγ receptor on B cells, provides immunoglobulin G (IgG)-mediated negative modulation through a tyrosine-based inhibition motif, which down-regulates B cell receptor-initiated signaling. These properties make FcγRIIb a promising target for antibody-based therapy. We report the discovery of allele-dependent expression of the activating FcγRIIc on B cells. Identical to FcγRIIb in the extracellular domain, FcγRIIc has a tyrosine-based activation motif in its cytoplasmic domain. In both human B cells and B cells from mice transgenic for human FcγRIIc, FcγRIIc expression counterbalances the negative feedback of FcγRIIb and enhances humoral responses to immunization in mice and to BioThrax vaccination in a human anthrax vaccine trial. Moreover, the FCGR2C-ORF allele is associated with the risk of development of autoimmunity in humans. FcγRIIc expression on B cells challenges the prevailing paradigm of unidirectional negative feedback by IgG immune complexes via the inhibitory FcγRIIb, is a previously unrecognized determinant in human antibody/autoantibody responses, and opens the opportunity for more precise personalized use of B cell-targeted antibody-based therapy.
AuthorsXinrui Li, Jianming Wu, Travis Ptacek, David T Redden, Elizabeth E Brown, Graciela S Alarcón, Rosalind Ramsey-Goldman, Michelle A Petri, John D Reveille, Richard A Kaslow, Robert P Kimberly, Jeffrey C Edberg
JournalScience translational medicine (Sci Transl Med) Vol. 5 Issue 216 Pg. 216ra175 (Dec 18 2013) ISSN: 1946-6242 [Electronic] United States
PMID24353158 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthrax Vaccines
  • Codon, Terminator
  • FCGR2B protein, human
  • Fc gamma receptor IIC
  • Receptors, Antigen, B-Cell
  • Receptors, IgG
Topics
  • Adult
  • Alleles
  • Animals
  • Anthrax Vaccines (administration & dosage)
  • Autoimmunity (genetics)
  • B-Lymphocytes (immunology)
  • Base Sequence
  • Cell Line
  • Codon, Terminator (genetics)
  • Female
  • Gene Expression
  • Homozygote
  • Humans
  • Immunity, Humoral
  • Male
  • Mice
  • Mice, Transgenic
  • Middle Aged
  • Open Reading Frames
  • Polymorphism, Single Nucleotide
  • Protein Structure, Tertiary
  • Receptors, Antigen, B-Cell (metabolism)
  • Receptors, IgG (chemistry, genetics, metabolism)
  • Signal Transduction
  • Translational Research, Biomedical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: